 | • レポートコード：MRC2012A0532 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗凝固薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗凝固薬の種類別市場規模（NOAC、ヘパリン、ワルファリン、その他）、用途別市場規模（病院、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、Johnson & Johnson、Bayer、Daiichi Sankyo、Pfizer、Boehringer Ingelheim、Sanofi、 ・地域別グローバル市場分析 2015年-2020年 ・抗凝固薬の北米市場（アメリカ、カナダ、メキシコ） ・抗凝固薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗凝固薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗凝固薬の南米市場（ブラジル、アルゼンチン） ・抗凝固薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：NOAC、ヘパリン、ワルファリン、その他 ・用途別分析：病院、薬局、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Anticoagulant Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Anticoagulant Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 33390 million by 2025, from USD 27900 million in 2019.
Market segmentation
Anticoagulant Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anticoagulant Drugs market has been segmented into
NOACs
Heparin
Warfarin
Others
By Application, Anticoagulant Drugs has been segmented into:
Hospital
Pharmacy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anticoagulant Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anticoagulant Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anticoagulant Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anticoagulant Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anticoagulant Drugs Market Share Analysis
Anticoagulant Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anticoagulant Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anticoagulant Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anticoagulant Drugs are:
Bristol-Myers Squibb
Johnson & Johnson
Bayer
Daiichi Sankyo
Pfizer
Boehringer Ingelheim
Sanofi
Among other players domestic and global, Anticoagulant Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulant Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulant Drugs, with price, sales, revenue and global market share of Anticoagulant Drugs in 2018 and 2019.
Chapter 3, the Anticoagulant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anticoagulant Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anticoagulant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anticoagulant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticoagulant Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 NOACs
1.2.3 Heparin
1.2.4 Warfarin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticoagulant Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Overview of Global Anticoagulant Drugs Market
1.4.1 Global Anticoagulant Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo SWOT Analysis
2.4.4 Daiichi Sankyo Product and Services
2.4.5 Daiichi Sankyo Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Product and Services
2.6.4 Boehringer Ingelheim Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Product and Services
2.7.4 Sanofi Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anticoagulant Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anticoagulant Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticoagulant Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anticoagulant Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anticoagulant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulant Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anticoagulant Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anticoagulant Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anticoagulant Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anticoagulant Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anticoagulant Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.4 France Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anticoagulant Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anticoagulant Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anticoagulant Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anticoagulant Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.5 India Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anticoagulant Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anticoagulant Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anticoagulant Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anticoagulant Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anticoagulant Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anticoagulant Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anticoagulant Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anticoagulant Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anticoagulant Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anticoagulant Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anticoagulant Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anticoagulant Drugs Price by Type (2015-2020)
11 Global Anticoagulant Drugs Market Segment by Application
11.1 Global Anticoagulant Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anticoagulant Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anticoagulant Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anticoagulant Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anticoagulant Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anticoagulant Drugs Market Forecast (2021-2025)
12.2.2 Europe Anticoagulant Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anticoagulant Drugs Market Forecast (2021-2025)
12.2.4 South America Anticoagulant Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anticoagulant Drugs Market Forecast (2021-2025)
12.3 Anticoagulant Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anticoagulant Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anticoagulant Drugs Market Share Forecast by Type (2021-2025)
12.4 Anticoagulant Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anticoagulant Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anticoagulant Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anticoagulant Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anticoagulant Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anticoagulant Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Anticoagulant Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol-Myers Squibb Anticoagulant Drugs Major Business
Table 10. Bristol-Myers Squibb Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Bristol-Myers Squibb SWOT Analysis
Table 12. Bristol-Myers Squibb Anticoagulant Drugs Product and Services
Table 13. Bristol-Myers Squibb Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 15. Johnson & Johnson Anticoagulant Drugs Major Business
Table 16. Johnson & Johnson Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Johnson & Johnson SWOT Analysis
Table 18. Johnson & Johnson Anticoagulant Drugs Product and Services
Table 19. Johnson & Johnson Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Bayer Basic Information, Manufacturing Base and Competitors
Table 21. Bayer Anticoagulant Drugs Major Business
Table 22. Bayer Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Bayer SWOT Analysis
Table 24. Bayer Anticoagulant Drugs Product and Services
Table 25. Bayer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 27. Daiichi Sankyo Anticoagulant Drugs Major Business
Table 28. Daiichi Sankyo Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Daiichi Sankyo SWOT Analysis
Table 30. Daiichi Sankyo Anticoagulant Drugs Product and Services
Table 31. Daiichi Sankyo Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Pfizer Basic Information, Manufacturing Base and Competitors
Table 33. Pfizer Anticoagulant Drugs Major Business
Table 34. Pfizer Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Pfizer SWOT Analysis
Table 36. Pfizer Anticoagulant Drugs Product and Services
Table 37. Pfizer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 39. Boehringer Ingelheim Anticoagulant Drugs Major Business
Table 40. Boehringer Ingelheim Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Boehringer Ingelheim SWOT Analysis
Table 42. Boehringer Ingelheim Anticoagulant Drugs Product and Services
Table 43. Boehringer Ingelheim Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Sanofi Basic Information, Manufacturing Base and Competitors
Table 45. Sanofi Anticoagulant Drugs Major Business
Table 46. Sanofi Anticoagulant Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Sanofi SWOT Analysis
Table 48. Sanofi Anticoagulant Drugs Product and Services
Table 49. Sanofi Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Anticoagulant Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Anticoagulant Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Anticoagulant Drugs Sales by Regions (2015-2020) (K Units)
Table 53. Global Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 54. Global Anticoagulant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 56. North America Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 57. North America Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 60. Europe Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 61. Europe Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Anticoagulant Drugs Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Anticoagulant Drugs Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Anticoagulant Drugs Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 66. South America Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 67. South America Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Anticoagulant Drugs Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Anticoagulant Drugs Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Table 73. Global Anticoagulant Drugs Sales by Type (2015-2020) (K Units)
Table 74. Global Anticoagulant Drugs Sales Share by Type (2015-2020)
Table 75. Global Anticoagulant Drugs Revenue by Type (2015-2020) (USD Million)
Table 76. Global Anticoagulant Drugs Revenue Share by Type (2015-2020)
Table 77. Global Anticoagulant Drugs Sales by Application (2015-2020) (K Units)
Table 78. Global Anticoagulant Drugs Sales Share by Application (2015-2020)
Table 79. Global Anticoagulant Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Anticoagulant Drugs Market Share Forecast by Regions (2021-2025)
Table 81. Global Anticoagulant Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Anticoagulant Drugs Market Share Forecast by Type (2021-2025)
Table 83. Global Anticoagulant Drugs Sales Forecast by Application (2021-2025)
Table 84. Global Anticoagulant Drugs Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anticoagulant Drugs Picture
Figure 2. Global Sales Market Share of Anticoagulant Drugs by Type in 2019
Figure 3. NOACs Picture
Figure 4. Heparin Picture
Figure 5. Warfarin Picture
Figure 6. Others Picture
Figure 7. Anticoagulant Drugs Sales Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Pharmacy Picture
Figure 10. Others Picture
Figure 11. Global Anticoagulant Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Anticoagulant Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Anticoagulant Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Anticoagulant Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Anticoagulant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Anticoagulant Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Anticoagulant Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Anticoagulant Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Anticoagulant Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Anticoagulant Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Anticoagulant Drugs Sales Market Share by Countries in 2018
Figure 48. North America Anticoagulant Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Anticoagulant Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Anticoagulant Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Anticoagulant Drugs Revenue Market Share by Regions 2019
Figure 64. China Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Anticoagulant Drugs Sales Market Share by Countries in 2019
Figure 71. South America Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Anticoagulant Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Anticoagulant Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Anticoagulant Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Anticoagulant Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Anticoagulant Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Anticoagulant Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Anticoagulant Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Anticoagulant Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
抗凝固剤の世界市場（～2026年） Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for…- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- タイサブリ薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tysabri Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tysabri Drugs market report pro…
- イロプロスト治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Iloprost Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…